Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Siddaway

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Nature Communications|December 5, 2020
Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancerSanja Pajovic, Robert Siddaway, Taylor Bridge, et al.
Acta Neuropathologica Communications|September 1, 2016
Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic gliomaScott Ryall, Rahul Krishnatry, Anthony Arnoldo, et al.
JCO Precision Oncology|October 30, 2025
Virtual CNS Tumor Board Rounds Within the Canadian Adolescent and Young Adult Neuro-Oncology NetworkBiren Dave, Mikayla Machado, Robert Siddaway, et al.
Nature Communications|November 5, 2015
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitmentStefanie Riesenberg, Angela Groetchen, Robert Siddaway, et al.
Brain Tumor Pathology|September 24, 2024
Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine gliomaNaohide Fujita, Andrew Bondoc, Sergio Simoes, et al.
Research Square|February 6, 2026
PTPN11-Related Noonan Syndrome Predisposes to Multifocal Low-Grade CNS Tumors Harboring FGFR1 VariantsGary Kohanbash, Scott Ryall, Sam E Gary, et al.
Journal of Neuro-Oncology|March 5, 2026
PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variantsGary Kohanbash, Scott Ryall, Sam E Gary, et al.
Acta Neuropathologica|September 7, 2022
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade gliomaRobert Siddaway, Laura Canty, Sanja Pajovic, et al.
Nature Communications|July 10, 2024
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironmentAdrian B Levine, Liana Nobre, Anirban Das, et al.
Genes & Development|January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPaola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Nature Communications|December 5, 2020
Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancerSanja Pajovic, Robert Siddaway, Taylor Bridge, et al.
Acta Neuropathologica Communications|September 1, 2016
Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic gliomaScott Ryall, Rahul Krishnatry, Anthony Arnoldo, et al.
JCO Precision Oncology|October 30, 2025
Virtual CNS Tumor Board Rounds Within the Canadian Adolescent and Young Adult Neuro-Oncology NetworkBiren Dave, Mikayla Machado, Robert Siddaway, et al.
Nature Communications|November 5, 2015
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitmentStefanie Riesenberg, Angela Groetchen, Robert Siddaway, et al.
Brain Tumor Pathology|September 24, 2024
Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine gliomaNaohide Fujita, Andrew Bondoc, Sergio Simoes, et al.
Research Square|February 6, 2026
PTPN11-Related Noonan Syndrome Predisposes to Multifocal Low-Grade CNS Tumors Harboring FGFR1 VariantsGary Kohanbash, Scott Ryall, Sam E Gary, et al.
Journal of Neuro-Oncology|March 5, 2026
PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variantsGary Kohanbash, Scott Ryall, Sam E Gary, et al.
Acta Neuropathologica|September 7, 2022
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade gliomaRobert Siddaway, Laura Canty, Sanja Pajovic, et al.
Nature Communications|July 10, 2024
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironmentAdrian B Levine, Liana Nobre, Anirban Das, et al.
Genes & Development|January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPaola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
Pageof 5